Brought to you by 
TVM company AurKa Pharma raises undisclosed Series A capital
21 Nov 2016
Executive Summary
Cancer-focused AurKa Pharma Inc. raised an undisclosed sum in its Series A financing round. The company is developing a compound originally discovered by Eli Lilly for solid tumors including small cell lung cancer and treatment resistant breast cancer.
Deal Industry
- Biotechnology
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
TVM company AurKa Pharma raises undisclosed Series A capital
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice